Literature DB >> 15042463

Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo.

N R Bolo1, Y Hodé, J-P Macher.   

Abstract

Fluorine magnetic resonance spectroscopy (19F MRS), spectroscopic imaging (MRSI) and proton anatomical magnetic resonance imaging (1H MRI) were performed on brains and lower extremities of six subjects in vivo concurrently with HPLC of serum to investigate tissue and plasma drug localization and withdrawal kinetics in humans treated with fluvoxamine or fluoxetine. 19F MRS signal was unexpectedly detected in the lower extremities months after complete disappearance of signal from plasma and brain. MRSI suggested that the lower extremity fluvoxamine signal originated mainly from bone marrow. Results suggest long-term sequestration of these drugs or their metabolites mainly in bone marrow and possibly in surrounding tissue and demonstrate the usefulness of MRS to reveal drug-trapping compartments in the body.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042463     DOI: 10.1007/s10334-004-0033-0

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  7 in total

Review 1.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

2.  Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells.

Authors:  Elisabeth A Riksen; Astrid K Stunes; Anne Kalvik; Björn I Gustafsson; Malcolm L Snead; Unni Syversen; Ståle P Lyngstadaas; Janne E Reseland
Journal:  Eur J Oral Sci       Date:  2010-09-30       Impact factor: 2.612

3.  The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice.

Authors:  Vivian Bradaschia-Correa; Anne M Josephson; Devan Mehta; Matthew Mizrahi; Shane S Neibart; Chao Liu; Oran D Kennedy; Alesha B Castillo; Kenneth A Egol; Philipp Leucht
Journal:  J Bone Miner Res       Date:  2017-02-27       Impact factor: 6.741

Review 4.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

5.  Citalopram and sertraline exposure compromises embryonic bone development.

Authors:  D Fraher; J M Hodge; F M Collier; J S McMillan; R L Kennedy; M Ellis; G C Nicholson; K Walder; S Dodd; M Berk; J A Pasco; L J Williams; Y Gibert
Journal:  Mol Psychiatry       Date:  2015-09-08       Impact factor: 15.992

6.  The effect of selective serotonin reuptake inhibitors on the human mandible.

Authors:  Aykağan Coşgunarslan; Firdevs Aşantoğrol; Damla Soydan Çabuk; Emin Murat Canger
Journal:  Oral Radiol       Date:  2020-01-02       Impact factor: 1.852

7.  Systemic effects of fluoxetine on the amount of tooth movement, root resorption, and alveolar bone remodeling during orthodontic force application in rat.

Authors:  Mehdi Rafiei; Soosan Sadeghian; Nakisa Torabinia; Valiollah Hajhashemi
Journal:  Dent Res J (Isfahan)       Date:  2015 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.